• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌患者的全直肠系膜切除术及术前放疗:良好的初步结果

[Total mesorectal excision and preoperative radiotherapy in patients with rectal carcinoma: good preliminary results].

作者信息

Bartelink H

机构信息

Het Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis, afd. Radiotherapie, Plesmanlaan 121, 1066 CX Amsterdam.

出版信息

Ned Tijdschr Geneeskd. 2001 Nov 24;145(47):2259-60.

PMID:11760604
Abstract

The value of a short course of radiotherapy prior to total mesorectal excision was studied in patients with resectable rectal cancer. The new surgical technique of total mesorectal excision was introduced under appropriate supervision and gave favourable treatment results. The incidence of local recurrence was markedly reduced by preoperative radiotherapy. Long term results should give greater insight into potential improvements in survival rates and any late side effects which may arise as a result of the radiation schedule.

摘要

在可切除直肠癌患者中,研究了全直肠系膜切除术前短程放疗的价值。全直肠系膜切除这一新的手术技术是在适当监督下引入的,且取得了良好的治疗效果。术前放疗显著降低了局部复发率。长期结果将更深入地了解生存率的潜在改善情况以及因放疗方案可能出现的任何晚期副作用。

相似文献

1
[Total mesorectal excision and preoperative radiotherapy in patients with rectal carcinoma: good preliminary results].直肠癌患者的全直肠系膜切除术及术前放疗:良好的初步结果
Ned Tijdschr Geneeskd. 2001 Nov 24;145(47):2259-60.
2
[Local recurrence and survival rate after rectal cancer operations and multimodal therapy].[直肠癌手术及多模式治疗后的局部复发率和生存率]
Chirurg. 2002 Mar;73(3):245-54. doi: 10.1007/s00104-002-0428-2.
3
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
4
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.部分T3期直肠癌患者术前放化疗后采用局部切除的长期结果。
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105. doi: 10.1016/j.ijrobp.2004.04.062.
5
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.短程术前放疗联合全直肠系膜切除术治疗直肠癌的晚期副作用:放疗患者肠道功能障碍增加——一项荷兰结直肠癌研究组的研究
J Clin Oncol. 2005 Sep 1;23(25):6199-206. doi: 10.1200/JCO.2005.14.779.
6
The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.TME试验,中位随访6年:可切除直肠癌放疗患者的局部控制率提高,但无生存获益。
Ann Surg. 2007 Nov;246(5):693-701. doi: 10.1097/01.sla.0000257358.56863.ce.
7
Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.全直肠系膜切除术治疗直肠癌患者术前放疗的成本效用分析:荷兰结直肠癌研究组的一项研究
J Clin Oncol. 2004 Jan 15;22(2):244-53. doi: 10.1200/JCO.2004.04.198. Epub 2003 Dec 9.
8
Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.肿瘤消退评估在预测接受术前放疗的局部晚期直肠癌患者预后中的重要性。
Cancer. 2002 Feb 15;94(4):1121-30.
9
Rectal carcinoma treated with short-term preoperative radiotherapy followed by abdominoperineal resection. Significantly more presacral abscesses with absence of local recurrence.采用术前短期放疗后行腹会阴联合切除术治疗直肠癌。骶前脓肿明显增多且无局部复发。
Dig Surg. 2006;23(3):173-7; discussion 177-8. doi: 10.1159/000094552. Epub 2006 Jul 10.
10
Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?在全直肠系膜切除时代,术后放疗对直肠癌是否有用?
Hepatogastroenterology. 2002 Mar-Apr;49(44):399-403.